Electronics Hospital Provider Telehealth 
Physician's Weekly
JUNE 17, 2025
TUESDAY, June 17, 2025 (HealthDay News) — Receipt of a stimulant prescription for attention-deficit/hyperactivity disorder (ADHD) via telehealth is not associated with an increased risk for substance use disorder (SUD), according to a study published online June 11 in The American Journal of Psychiatry. Vinod Rao, M.D., Vinod Rao, M.D.,
FDA Law
JANUARY 5, 2023
Claud — As we turn into the New Year, we offer a few items of interest in digital and telehealth regulation, enforcement, and compliance that may provide some helpful guideposts for stakeholders. Digital providers and manufacturers not only have the concerns of the FDA to consider, but those of the FTC as well. By John W.M.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
FDA Law
JUNE 21, 2023
telemedicine and telehealth solutions (e.g., enable individuals to have virtual consultations with healthcare providers through video calls or online platforms), at-home diagnostics (e.g., telemedicine and telehealth solutions (e.g., pregnancy tests, blood glucose monitoring systems, COVID-19 tests, etc.),
GeriPal
MARCH 28, 2024
Kate: The problem is we communicate late, we share prognosis late, we elicit goals and values late, so all the time while they’re in the ICU getting prolonged intensive care, we don’t really know that we’re providing goal concordant care, so we wanted to nudge it a little upstream. Also the same hospital system?
GeriPal
JULY 20, 2023
This DEA is taking 6-months to consider how to move forward vis a vis restrictions and requirements for telehealth in a post-pandemic world. So we’re going to be talking about telemedicine, telehealth for people with serious illness. What was life for you as a provider pre-pandemic? This is Eric Widera. Brooke: Thank you.
Expert insights. Personalized for you.
52 
Let's personalize your content